🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label safety and feasibility trial using Acthar® in additio...
Status
Withdrawn
Location
University of North Carolina at Chapel Hill
Start Date
2021-03
Trial ID
NCT02399462
Treatments Being Tested
Focal segmental glomerulosclerosis (FSGS) is a condition that harms the kid...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-10-10
Trial ID
NCT02633046
Treatments Being Tested
The purpose of this study is to evaluate the effect of adrenocorticotropic ...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2018-03-19
Trial ID
NCT03025828
Treatments Being Tested
This is a phase II, open-label, 12-month pilot study in 10 patients with si...
Status
Terminated
Location
Neuroendocrine Unit and Pituitary Center, Columbia University
Start Date
2017-07-10
Trial ID
NCT02749227
Treatments Being Tested
The purpose of this study is to evaluate the effect of a medication called ...
Status
Completed
Location
University at Buffalo-State University of New York, Department of Neurology, Buffalo General Hospital
Start Date
2013-08
Trial ID
NCT02290444
Treatments Being Tested
This is a study of Acthar gel (ACTH) in patients with relapsing multiple sc...
Status
Completed
Location
North Central Neurology Associates, PC
Start Date
2015-05-22
Trial ID
NCT02315872
About 213 people with ALS will participate in this study. There will be loc...
Status
Terminated
Location
Neuromuscular Research Center
Start Date
2017-06-22
Trial ID
NCT03068754
A Multicenter, Comparative Safety and Efficacy Study of Acthar gel alone or...
Status
Unknown
Location
Stanford University
Start Date
2019-03-14
Trial ID
NCT05546047
Treatments Being Tested
The purpose of this pilot study is to assess the safety and efficacy of Act...
Status
Withdrawn
Location
Phoenix Neurological Associates
Start Date
2015-08
Trial ID
NCT02574962
Treatments Being Tested
Patients will be assigned to receive either Depo Medrol or Acthar treatment...
Status
Unknown
Location
Attune Health
Start Date
2018-10-02
Trial ID
NCT03511625
Treatments Being Tested